AKBLF
Price:
$40.65
Market Cap:
$55.40B
Established in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allergy solutions to markets across Europe, North America, and other international regions. These offerings include immunotherapy products delivered through injections, sublingual drops, and oral tablets, designed to address various allergies such as those caused by house dust mites, grass, tree, ragweed, and Japanese cedar. ALK-Abelló also manufactures adrenaline auto-injectors for the critical management of severe allergic reactions and produces diagnostic tools essential for identifying allergic co...[Read more]
Industry
Biotechnology
IPO Date
2009-11-16
Stock Exchange
OTC
Ticker
AKBLF
According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current Current Ratio is 3.25. This represents a change of 13.75% compared to the average of 2.86 of the last 4 quarters.
The mean historical Current Ratio of ALK-Abelló A/S over the last ten years is 2.40. The current 3.25 Current Ratio has changed 13.43% with respect to the historical average. Over the past ten years (40 quarters), AKBLF's Current Ratio was at its highest in in the September 2018 quarter at 3.38. The Current Ratio was at its lowest in in the June 2021 quarter at 1.66.
Average
2.40
Median
2.34
Minimum
1.69
Maximum
3.38
Discovering the peaks and valleys of ALK-Abelló A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.08%
Maximum Annual Current Ratio = 3.38
Minimum Annual Increase = -25.18%
Minimum Annual Current Ratio = 1.69
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.38 | 100.08% |
| 2024 | 1.69 | -25.18% |
| 2023 | 2.26 | 19.47% |
| 2022 | 1.89 | 8.97% |
| 2021 | 1.74 | -23.70% |
| 2020 | 2.27 | -5.52% |
| 2019 | 2.41 | -12.59% |
| 2018 | 2.75 | -14.91% |
| 2017 | 3.24 | 33.84% |
| 2016 | 2.42 | 44.65% |
The current Current Ratio of ALK-Abelló A/S (AKBLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.44
5-year avg
2.19
10-year avg
2.40
ALK-Abelló A/S’s Current Ratio is less than Laboratorios Farmaceuticos Rovi, S.A. (3.66), less than Zealand Pharma A/S (37.17), greater than Shanghai Junshi Biosciences Co., Ltd. (2.14), less than InnoCare Pharma Limited (5.65), greater than Genscript Biotech Corporation (1.47), less than Camurus AB (publ) (11.57), greater than Clicks Group Limited (1.05), greater than Fielmann AG (1.19), greater than Getinge AB (publ) (1.35), greater than COSMOS Pharmaceutical Corporation (0.66),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.66 | $4.63B | |
| 37.17 | $3.16B | |
| 2.14 | $4.84B | |
| 5.65 | $2.32B | |
| 1.47 | $3.50B | |
| 11.57 | $3.21B | |
| 1.05 | $3.34B | |
| 1.19 | $4.17B | |
| 1.35 | $5.10B | |
| 0.66 | $2.94B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ALK-Abelló A/S's Current Ratio?
How is the Current Ratio calculated for ALK-Abelló A/S (AKBLF)?
What is the highest Current Ratio for ALK-Abelló A/S (AKBLF)?
What is the 3-year average Current Ratio for ALK-Abelló A/S (AKBLF)?
What is the 5-year average Current Ratio for ALK-Abelló A/S (AKBLF)?
How does the current Current Ratio for ALK-Abelló A/S (AKBLF) compare to its historical average?